{
    "2021-12-20": [
        [
            {
                "time": "2023-10-05",
                "original_text": "GSK vs. NVO: Which Stock Is the Better Value Option?",
                "features": {
                    "keywords": [
                        "GSK",
                        "NVO",
                        "value option"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novo Nordisk Shares Slump As Wegovy Hits US Supply Issues; Deutsche Bank Downgrades",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Wegovy",
                        "US supply issues",
                        "Deutsche Bank",
                        "downgrades"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novo Nordisk shares tank after key drug hope hit by U.S. supply issues",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "drug",
                        "U.S. supply issues"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Moderna, AT&T Rise Premarket; United Airlines, Tesla, Exxon Mobil Fall",
                "features": {
                    "keywords": [
                        "Moderna",
                        "AT&T",
                        "United Airlines",
                        "Tesla",
                        "Exxon Mobil"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "energy",
                        "transportation"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novo Nordisk Tumbles as Contractor Issues Hit U.S. Obesity Drug Supply",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "contractor issues",
                        "U.S. obesity drug supply"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}